Recently reported positive preliminary data from Phase 1 dose escalation trial of micvotabart pelidotin (“MICVO,” formerly PYX-201), including ...

If you suffered losses exceeding $100,000 in Merck between February 3, 2022 and February 3, 2025 and would like to discuss ...

Novartis Pharmaceuticals is removing hundreds of New Jersey employees from its company. The global drugmaker will lay off 427 ...

Investing.com – U.S. stocks were lower after the close on Monday, as losses in the Consumer Services, Technology and Basic ...

“Due to significant reductions in demand for these products, the company has decided to cease operations at the plant,” the ...